Reorganisation key for Piramal Enterprise

Hamsini Karthik |  Sep 21, 2016 10:21 PM IST

The mention of Piramal could bring back memories of its deal with Abbott India, when Piramal Healthcare sold its formulation business for about Rs 17,000 crore. A lot has changed since and the Street’s interest in Piramal Enterprise’s stock, too, gradually receded. For instance, Sarabjit Kour Nangra, vice-president of Research, Angel Broking, who had an active coverage on Piramal Healthcare says after the sale, the residual businesses were only cash and contract research and manufacturing. So, not many analysts tracked it. However,.....

TO READ THE FULL STORY, SUBSCRIBE NOW

Already a premium subscriber? LOGIN NOW.

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.

 

  
X

Share Box

Permalink